These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 4062330)
21. [Current state and prospects of the use of cygnoline in the treatment of psoriasis]. Ciesielska J Przegl Dermatol; 1985; 72(1):77-90. PubMed ID: 3892593 [No Abstract] [Full Text] [Related]
26. [Effect of the treatment of psoriasis with dithranol in comparison with a combination of dithranol and a corticosteroid]. Gloor M; Graf R; Wirth H; Landau M Hautarzt; 1983 Oct; 34(10):500-3. PubMed ID: 6643055 [TBL] [Abstract][Full Text] [Related]
30. [Suppression of dithranol erythema by the addition of tar in short-term therapy]. Wozel G; Barth J Dermatol Monatsschr; 1985; 171(12):818-9. PubMed ID: 4092792 [No Abstract] [Full Text] [Related]
32. Short contact dithranol therapy--twice daily and high concentration regimes. Statham BN; Rowell NR Br J Dermatol; 1985 Aug; 113(2):245-6. PubMed ID: 4027191 [No Abstract] [Full Text] [Related]
33. [The effect of a tar admixture to dithranol-salicylic-acid-white-petrolatum therapy on the cytokinetics of psoriasis]. Schulze HJ; Steigleder GK; Pullmann H; Bloedhorn H Z Hautkr; 1984 Mar; 59(5):288-90, 295-7. PubMed ID: 6719979 [TBL] [Abstract][Full Text] [Related]
34. Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses. Brun P; Juhlin L; Schalla W Acta Derm Venereol; 1984; 64(2):174-7. PubMed ID: 6203312 [TBL] [Abstract][Full Text] [Related]
35. New chemical stabilizers, vehicles and delivery systems to enhance efficacy of low strength anthralin formulations. van Scott EJ; Yu RJ Br J Dermatol; 1981 Aug; 105 Suppl 20():35-8. PubMed ID: 7284262 [No Abstract] [Full Text] [Related]
36. An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children. Guerrier CJ; Porter DI Curr Med Res Opin; 1983; 8(6):446-50. PubMed ID: 6342960 [TBL] [Abstract][Full Text] [Related]
37. A comparative study of dithranol cream, 0.25% and 0.1%, and dithranol ointment 0.25% in the treatment of psoriasis. Fredriksson T Pharmatherapeutica; 1983; 3(7):496-8. PubMed ID: 6366807 [TBL] [Abstract][Full Text] [Related]
38. Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy. Schaefer H; Farber EM; Goldberg L; Schalla W Br J Dermatol; 1980 May; 102(5):571-3. PubMed ID: 7387901 [TBL] [Abstract][Full Text] [Related]
39. Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis. Lowe NJ; Breeding J Arch Dermatol; 1981 Nov; 117(11):698-700. PubMed ID: 7316528 [TBL] [Abstract][Full Text] [Related]
40. Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: assessment of efficacy. Lebwohl M; Berman B; France DS J Am Acad Dermatol; 1985 Nov; 13(5 Pt 1):780-4. PubMed ID: 4078074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]